Enhanced Vascular Function Following Intake of Feruloyl Esterase-processed High Fibre Bread.
NCT ID: NCT03946293
Last Updated: 2019-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2015-01-05
2015-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increasing Ferulic Acid Bioavailability in Bran
NCT00777543
Bioavailability of Phenolic Compounds in Bread
NCT02353234
Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS)
NCT02693782
Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol
NCT00981981
Whole Grain Polyphenol Bioavailability and Effects on Health
NCT01293175
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the present study was therefore to determine whether the intake of high fibre bread containing higher free ferulic acid levels (enzymatically released during processing) enhances human endothelium-dependent vascular function to a greater extent than that of traditional wholegrain bread and/or a white bread control.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
White bread
White bread 3 x 30 g, single serving
White Bread
White bread made with commercial white flour with bran/fibre removed
Wholegrain
Standard wholegrain, 3 x 30 g, single serving
Wholegrain bread
Wholegrain bread made with commercial wholegrain flour.
Wholegrain Enzyme
Enzyme-treated wholegrain, 3 x 30 g, single serving
Wholegrain Enzyme
Wholegrain bread made with enzyme-treated commercial wholegrain flour.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
White Bread
White bread made with commercial white flour with bran/fibre removed
Wholegrain bread
Wholegrain bread made with commercial wholegrain flour.
Wholegrain Enzyme
Wholegrain bread made with enzyme-treated commercial wholegrain flour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biotechnology and Biological Sciences Research Council
OTHER
University of Reading
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeremy Paul Edward Spencer
Professor of Nutritional Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Food and Nutritional Sciences
Reading, Berkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Turner AL, Michaelson LV, Shewry PR, Lovegrove A, Spencer JPE. Increased bioavailability of phenolic acids and enhanced vascular function following intake of feruloyl esterase-processed high fibre bread: A randomized, controlled, single blind, crossover human intervention trial. Clin Nutr. 2021 Mar;40(3):788-795. doi: 10.1016/j.clnu.2020.07.026. Epub 2020 Aug 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Wholegrain_FMD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.